BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32671188)

  • 1. Tmub1 Suppresses Hepatocellular Carcinoma by Promoting the Ubiquitination of ΔNp63 Isoforms.
    Fu H; Zhang Y; Chen J; Zhou B; Chen G; Chen P
    Mol Ther Oncolytics; 2020 Sep; 18():126-136. PubMed ID: 32671188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transmembrane and Ubiquitin-Like Domain Containing 1 Protein (TMUB1) Negatively Regulates Hepatocellular Carcinoma Proliferation via Regulating Signal Transducer and Activator of Transcription 1 (STAT1).
    Chen Y; Fu H; Zhang Y; Chen P
    Med Sci Monit; 2019 Dec; 25():9471-9482. PubMed ID: 31827061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tmub1 negatively regulates liver regeneration via inhibiting STAT3 phosphorylation.
    Fu H; Dong R; Zhang Y; Xu J; Liu M; Chen P
    Cell Signal; 2019 Mar; 55():65-72. PubMed ID: 30610893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRIM52 up-regulation in hepatocellular carcinoma cells promotes proliferation, migration and invasion through the ubiquitination of PPM1A.
    Zhang Y; Tao R; Wu SS; Xu CC; Wang JL; Chen J; Yu YS; Tang ZH; Chen XH; Zang GQ
    J Exp Clin Cancer Res; 2018 Jun; 37(1):116. PubMed ID: 29898761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-27a/b Regulates Liver Regeneration by Posttranscriptional Modification of Tmub1.
    Lan X; Li G; Liu H; Fu H; Chen P; Liu M
    Dig Dis Sci; 2018 Sep; 63(9):2362-2372. PubMed ID: 29777440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoting anti-tumor immunity by targeting TMUB1 to modulate PD-L1 polyubiquitination and glycosylation.
    Shi C; Wang Y; Wu M; Chen Y; Liu F; Shen Z; Wang Y; Xie S; Shen Y; Sang L; Zhang Z; Gao Z; Yang L; Qu L; Yang Z; He X; Guo Y; Pan C; Che J; Ju H; Liu J; Cai Z; Yan Q; Yu L; Wang L; Dong X; Xu P; Shao J; Liu Y; Li X; Wang W; Zhou R; Zhou T; Lin A
    Nat Commun; 2022 Nov; 13(1):6951. PubMed ID: 36376293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmembrane and Ubiquitin-Like Domain-Containing 1 Promotes Glioma Growth and Indicates Unfavorable Prognosis.
    Liu Y; Cai C; Wu K; Hu L
    Int J Genomics; 2023; 2023():3318171. PubMed ID: 38148953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CCAAT/enhancer-binding protein β regulates interleukin-6-induced transmembrane and ubiquitin-like domain containing 1 gene expression in hepatocytes.
    Liu M; Yuan T; Liu H; Chen P
    Mol Med Rep; 2014 Oct; 10(4):2177-83. PubMed ID: 25109894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6 induction of hepatocyte proliferation through the Tmub1-regulated gene pathway.
    Liu M; Liu H; Wang X; Chen P; Chen H
    Int J Mol Med; 2012 Jun; 29(6):1106-12. PubMed ID: 22426572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer.
    Hao T; Yu H; Huang D; Liu Q
    Dis Markers; 2022; 2022():5884531. PubMed ID: 35928927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microarray analysis reveals Tmub1 as a cell cycle-associated protein in rat hepatocytes.
    Fu H; Xu J; Chen J; Li G; Zhao X; Chen P
    Mol Med Rep; 2018 Mar; 17(3):4337-4344. PubMed ID: 29344642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of PRAME Suppresses Proliferation and Promotes Apoptosis in Hepatocellular Carcinoma Through the Activation of P53 Mediated Pathway.
    Zhu H; Wang J; Yin J; Lu B; Yang Q; Wan Y; Jia C
    Cell Physiol Biochem; 2018; 45(3):1121-1135. PubMed ID: 29439259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC; Matheny KE; Westfall MD; Pietenpol JA
    Laryngoscope; 2004 Dec; 114(12):2063-72. PubMed ID: 15564824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TMUB1 Inhibits BRL-3A Hepatocyte Proliferation by Interfering with the Binding of CAML to Cyclophilin B through its TM1 Hydrophobic Domain.
    Lan X; Fu H; Li G; Zeng W; Lin X; Zhu Y; Liu M; Chen P
    Sci Rep; 2018 Jul; 8(1):9917. PubMed ID: 29967478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p63 and p73 isoforms on the cell death in patients with hepatocellular carcinoma submitted to orthotopic liver transplantation.
    González R; De la Rosa ÁJ; Rufini A; Rodríguez-Hernández MA; Navarro-Villarán E; Marchal T; Pereira S; De la Mata M; Müller-Schilling M; Pascasio-Acevedo JM; Ferrer-Ríos MT; Gómez-Bravo MA; Padillo FJ; Muntané J
    PLoS One; 2017; 12(3):e0174326. PubMed ID: 28350813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21.
    Zhang L; Chen J; Ning D; Liu Q; Wang C; Zhang Z; Chu L; Yu C; Liang HF; Zhang B; Chen X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):101. PubMed ID: 30808376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of TA and DeltaNp63 are regulated by different mechanisms in liver cells.
    Petitjean A; Cavard C; Shi H; Tribollet V; Hainaut P; Caron de Fromentel C
    Oncogene; 2005 Jan; 24(3):512-9. PubMed ID: 15543231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Speckle-type POZ protein suppresses hepatocellular carcinoma cell migration and invasion via ubiquitin-dependent proteolysis of SUMO1/sentrin specific peptidase 7.
    Ji P; Liang S; Li P; Xie C; Li J; Zhang K; Zheng X; Feng M; Li Q; Jiao H; Chi X; Zhao W; Zhang S; Wang X
    Biochem Biophys Res Commun; 2018 Jul; 502(1):30-42. PubMed ID: 29777712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ΔNp63 to TAp63 expression ratio as a potential molecular marker for cervical cancer prognosis.
    Park S; Lee S; Kim J; Kim G; Park KH; Kim TU; Chung D; Lee H
    PLoS One; 2019; 14(4):e0214867. PubMed ID: 30973901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Basolateral CD147 induces hepatocyte polarity loss by E-cadherin ubiquitination and degradation in hepatocellular carcinoma progress.
    Lu M; Wu J; Hao ZW; Shang YK; Xu J; Nan G; Li X; Chen ZN; Bian H
    Hepatology; 2018 Jul; 68(1):317-332. PubMed ID: 29356040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.